- FDA approved Onswik for adults with type 2 diabetes
The FDA approved Eli Lilly's Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin injection for adults with type 2 diabetes. Lilly says the treatment could reduce injections by over 300 per year versus daily basal insulin. U.S. availability expected in coming months.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.